Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01565135 · ClinicalTrials.gov registry record · NA
Immunization Delivery in Obstetrics and Gynecology Settings
A NA study of Immunization Status Among Obstetrics and Gynecology Patients, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 97,087
- Enrollment target
- 1
- Study location
NCT01565135 is a NA study of Immunization Status Among Obstetrics and Gynecology Patients that has completed, run by University of Colorado, Denver. The registered enrollment target is 97,087 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01565135, a NA study of Immunization Status Among Obstetrics and Gynecology Patients, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 97,087 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if a multimodal immunization program carried out in obstetrics and gynecology (ob/gyn) practices would be more effective in improving ob/gyn patients' immunization rates, specifically for Tdap (Tetanus, Diphtheria, Pertussis), HPV (Human papilloma virus), and influenza vaccines, than the usual care provided to patients in ob/gyn practices.
Conditions Studied
Interventions
- BEHAVIORAL Multimodal Vaccine Program
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97,087 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01565135
The ClinicalTrials.gov registry entry for NCT01565135 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97,087 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Immunization Status Among Obstetrics and Gynecology Patients appearing as the primary indexed condition, and to 1 intervention - of which Multimodal Vaccine Program is the first listed.
NCT01565135 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01565135 about?
NCT01565135 is a clinical study titled "Immunization Delivery in Obstetrics and Gynecology Settings". The purpose of this study is to determine if a multimodal immunization program carried out in obstetrics and gynecology (ob/gyn) practices would be more effective in improving ob/gyn patients' immunization rates, specifically for Tdap (Tetanus, Diphtheria, Pertussis), HPV (Human papilloma virus), an...
What is the current status of trial NCT01565135?
This trial is currently completed. It is a NA study. The enrollment target is 97,087 participants. The study started on 2012-09. Estimated completion is 2015-10.
What conditions does trial NCT01565135 study?
This clinical trial studies the following conditions: Immunization Status Among Obstetrics and Gynecology Patients.
What interventions are being tested in trial NCT01565135?
The interventions under investigation include: Multimodal Vaccine Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01565135?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01565135 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.